AmerisourceBergen elevates Steve Collis to president and COO
The Big Three distributor’s board of directors has appointed Collis, currently president of AmerisourceBergen Drug Corp. (ABDC, the pharma wholesaling arm of the company) to president and chief operating officer of the parent. He will report to R. David Yost, AmerisourceBergen’s CEO, who previously also held the title of president.
Collis is now responsible for all AmerisourceBergen business units, including ABDC, AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Packaging Group (ABPG) and AmerisourceBergen Consulting Services (ABCS). ABSG and ABCS previously reported to Yost, and ABPG previously reported to Michael DiCandilo, EVP and CFO.
Collis, who has been at AmerisourceBergen for 16 years, has been president of ABSG since 1999; that unit is now a fast-growing, $16-billion part of the company. This month, the company also announced its FY2010 results, with revenue reaching a new record, $78.0 billion, up 8.6%, and gross profit of $2.4 billion, up 12.2%.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
